The outsourced service providers have signed a new collaboration agreement to provide global pharmaceutical and biotechnology clients access to electrophysiology and ion channel screening.
Metrion has invested in new laboratories, equipment, and staff, as part of the company's continued growth strategy to form strategic alliances and add "additional breadth."
Making sure candidate drugs are free of cardiac risks means drug industry demand for ion channel screening expertise is growing according to new CRO, Metrion.
Ion channel expert ChanTest is expanding its range of ion channel services and cell lines that help identify promising target compounds and those that could cause harmful side effects.
Pfizer has penned a discovery-stage deal with Icagen aimed at
finding potential pain alleviating drugs, but has forked out over
twice the industry average.
The worlds of biochemistry and electronics have collided after
scientists successfully developed a biosensor that can measure a
drug's effectiveness without killing the cells it is trying to
analyse.
A new method has revealed that a discovery involving menthol could
point towards new therapies to treat chronic inflammatory and
neuropathic pain indications by targeting the temperature-activated
ion channels.
Sophion Bioscience and Physio-Tech have signed an agreement in
which Physio-Tech will become the exclusive distributor of Qpatch
16 systems in Japan, signifying its introduction into the Asian
market.
Pfizer has entered a worldwide collaboration and licensing
agreement with Renovis to research, develop and commercialise small
molecules that target a receptor, which generates signals for
certain types of pain.
A new high throughput ion channel screening service has been
launched by BioFocus, which will allow pharmaceutical companies to
pre-screen libraries against defined cell lines, identifying target
compounds and limiting the use of...
Sweden's Cellectricon has launched a new microfluidic chip product
that promises to speed up the screening of drugs that interact with
ion channels, an important drug target that make up around 15 per
cent of all medicines on...
German biotech company flyion has developed a new technology which
speeds up drug development and could reduce the number of animals
needed in research.
Quintiles Transnational has launched a new screening technology for
drug discovery and development to detect the interaction of
compounds with ion channels.